{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:10:25Z","timestamp":1779376225948,"version":"3.53.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-026-08514-0","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:45:29Z","timestamp":1777527929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and early biochemical responses to botulinum toxin type-A in refractory masticatory myofascial pain: a pilot single-arm study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5855-4570","authenticated-orcid":false,"given":"Salih Eren","family":"Meral","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe","family":"Buru\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevilay","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuray","family":"Bayrak\u00e7\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Bayaz\u0131t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"issue":"1","key":"8514_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11607\/jop.1151","volume":"28","author":"E Schiffman","year":"2014","unstructured":"Schiffman E, et al. Diagnostic criteria for temporomandibular disorders (DC\/TMD) for clinical and research applications: recommendations of the International RDC\/TMD Consortium Network and Orofacial Pain Special Interest Group. J oral facial pain headache. 2014;28(1):6.","journal-title":"J oral facial pain headache"},{"key":"8514_CR2","doi-asserted-by":"publisher","first-page":"1306475","DOI":"10.3389\/fpain.2023.1306475","volume":"4","author":"G Barjandi","year":"2024","unstructured":"Barjandi G, et al. Clinical aspects of mastication myalgia\u2014an overview. Front Pain Res. 2024;4:1306475.","journal-title":"Front Pain Res"},{"key":"8514_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jbmt.2021.07.015","volume":"28","author":"M Kalladka","year":"2021","unstructured":"Kalladka M, Young A, Khan J. Myofascial pain in temporomandibular disorders: Updates on etiopathogenesis and management. J Bodyw Mov Ther. 2021;28:104\u201313.","journal-title":"J Bodyw Mov Ther"},{"key":"8514_CR4","doi-asserted-by":"crossref","unstructured":"Ernberg M. Masticatory muscle pain biomarkers. In: Goulet JPV, editor. Orofacial pain biomarkers. Springer. 2017. p. 79\u201393.","DOI":"10.1007\/978-3-662-53994-1_6"},{"issue":"1","key":"8514_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/sjpain-2022-0112","volume":"23","author":"H Jasim","year":"2023","unstructured":"Jasim H. Topical review\u2013salivary biomarkers in chronic muscle pain. Scandinavian J Pain. 2023;23(1):3\u201313.","journal-title":"Scandinavian J Pain"},{"key":"8514_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jdsr.2023.08.006","volume":"59","author":"E Farr\u00e9-Guasch","year":"2023","unstructured":"Farr\u00e9-Guasch E, et al. The role of inflammatory markers in Temporomandibular Myalgia: A systematic review. Japanese Dent Sci Rev. 2023;59:281\u20138.","journal-title":"Japanese Dent Sci Rev"},{"issue":"1","key":"8514_CR7","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/s41598-018-21131-4","volume":"8","author":"H Jasim","year":"2018","unstructured":"Jasim H, et al. Saliva as a medium to detect and measure biomarkers related to pain. Sci Rep. 2018;8(1):3220.","journal-title":"Sci Rep"},{"key":"8514_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","volume":"33","author":"M Matsuda","year":"2018","unstructured":"Matsuda M, Huh Y, Ji R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth. 2018;33:131\u20139.","journal-title":"J Anesth"},{"key":"8514_CR9","doi-asserted-by":"crossref","unstructured":"De la Torre Canales G, et al. Efficacy and safety of botulinum toxin type A on persistent myofascial pain: a randomized clinical trial. Toxins (Basel). 2020;12(6):395.","DOI":"10.3390\/toxins12060395"},{"issue":"1","key":"8514_CR10","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41598-024-54906-z","volume":"14","author":"T De la Canales","year":"2024","unstructured":"De la Canales T. Botulinum toxin-A effects on pain, somatosensory and psychosocial features of patients with refractory masticatory myofascial pain: a randomized double-blind clinical trial. Sci Rep. 2024;14(1):4201.","journal-title":"Sci Rep"},{"key":"8514_CR11","doi-asserted-by":"crossref","unstructured":"Dekhne A, et al. Effectiveness of botulinum toxin in the treatment of neuropathic pain: a literature review. Cureus, 2023;5(10):e47389.","DOI":"10.7759\/cureus.46848"},{"issue":"7","key":"8514_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s40265-024-02048-x","volume":"84","author":"T De la Canales","year":"2024","unstructured":"De la Canales T. Botulinum Toxin-A for the treatment of Myogenous Temporomandibular disorders: an Umbrella Review of systematic reviews. Drugs. 2024;84(7):779\u2013809.","journal-title":"Drugs"},{"issue":"8","key":"8514_CR13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/toxins11080459","volume":"11","author":"I Matak","year":"2019","unstructured":"Matak I, et al. Mechanisms of botulinum toxin type A action on pain. Toxins. 2019;11(8):459.","journal-title":"Toxins"},{"key":"8514_CR14","doi-asserted-by":"crossref","unstructured":"Novo Pereira I, De la Torre Canales G, Dur\u00e3o S, Shado R, Braga AC, Almeida AM, et al. Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of preclinical research. Toxins (Basel). 2025;17(8):377.","DOI":"10.3390\/toxins17080377"},{"issue":"1","key":"8514_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/08869634.2018.1562660","volume":"39","author":"SE Meral","year":"2021","unstructured":"Meral SE, T\u00fcz HH, Ba\u015flarl\u0131 \u00d6. Evaluation of patient satisfaction after botulinum toxin A injection for the management of masticatory myofascial pain and dysfunction\u2013A pilot study. CRANIO\u00ae. 2021;39(1):12\u20136.","journal-title":"CRANIO\u00ae"},{"issue":"10","key":"8514_CR16","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3390\/toxins15100597","volume":"15","author":"SR Kim","year":"2023","unstructured":"Kim SR, et al. Effect of botulinum toxin on masticatory muscle pain in patients with temporomandibular disorders: a randomized, double-blind, placebo-controlled pilot study. Toxins. 2023;15(10):597.","journal-title":"Toxins"},{"issue":"1","key":"8514_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.joms.2020.09.013","volume":"79","author":"O Yilmaz","year":"2021","unstructured":"Yilmaz O, et al. Comparison of the efficacy of botulinum toxin, local anesthesia, and platelet-rich plasma injections in patients with myofascial trigger points in the masseter muscle. J Oral Maxillofac Surg. 2021;79(1):88. e1-88. e9.","journal-title":"J Oral Maxillofac Surg"},{"issue":"7","key":"8514_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/toxins14070441","volume":"14","author":"T De la Canales","year":"2022","unstructured":"De la Canales T. Efficacy of botulinum toxin type-A I in the improvement of mandibular motion and muscle sensibility in myofascial pain TMD Subjects: A randomized controlled trial. Toxins. 2022;14(7):441.","journal-title":"Toxins"},{"issue":"5","key":"8514_CR19","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/pmt-2020-0045","volume":"11","author":"E Miotto","year":"2021","unstructured":"Miotto E, et al. Effect of botulinum toxin on quality of life of patients with chronic myofascial pain. Pain Manage. 2021;11(5):583\u201393.","journal-title":"Pain Manage"},{"key":"8514_CR20","doi-asserted-by":"crossref","unstructured":"Rahmatipour H, Shabestari SM, Benisi SZ, Samadikhah H. Pioneering pain management with botulinum toxin type A: from anti-inflammation to regenerative therapies. Heliyon. 2025;11(4):e42166.","DOI":"10.1016\/j.heliyon.2025.e42350"},{"issue":"11","key":"8514_CR21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3390\/toxins14110741","volume":"14","author":"T De la Canales","year":"2022","unstructured":"De la Canales T. Long-term effects of a single application of botulinum toxin type A in temporomandibular myofascial pain patients: a controlled clinical trial. Toxins. 2022;14(11):741.","journal-title":"Toxins"},{"issue":"3","key":"8514_CR22","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2105\/AJPH.94.3.361","volume":"94","author":"DC Des Jarlais","year":"2004","unstructured":"Des Jarlais DC, et al. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361\u20136.","journal-title":"Am J Public Health"},{"key":"8514_CR23","unstructured":"Begum MR, Hossain MA. Validity and reliability of visual analogue scale (VAS) for pain measurement. J Med Case Rep Rev. 2019;2(11):394\u2013402."},{"issue":"9","key":"8514_CR24","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1365-2842.2009.01980.x","volume":"36","author":"R La Touche","year":"2009","unstructured":"La Touche R, et al. The effects of manual therapy and exercise directed at the cervical spine on pain and pressure pain sensitivity in patients with myofascial temporomandibular disorders. J Rehabil. 2009;36(9):644\u201352.","journal-title":"J Rehabil"},{"issue":"1","key":"8514_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jormas.2018.10.007","volume":"120","author":"S Villa","year":"2019","unstructured":"Villa S, et al. Improvement in quality of life after botulinum toxin injection for temporomandibular disorder. J stomatology oral maxillofacial Surg. 2019;120(1):2\u20136.","journal-title":"J stomatology oral maxillofacial Surg"},{"issue":"12","key":"8514_CR26","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1016\/j.joms.2019.06.005","volume":"77","author":"ME Yurttutan","year":"2019","unstructured":"Yurttutan ME, Sancak KT, T\u00fcz\u00fcner AM. Which treatment is effective for bruxism: occlusal splints or botulinum toxin? J Oral Maxillofac Surg. 2019;77(12):2431\u20138.","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"8514_CR27","doi-asserted-by":"publisher","first-page":"e562","DOI":"10.1097\/PRS.0000000000009444","volume":"150","author":"K-H Yi","year":"2022","unstructured":"Yi K-H, et al. Guidelines for botulinum neurotoxin injection for facial contouring. Plast Reconstr Surg. 2022;150(3):e562\u201371.","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"8514_CR28","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3390\/toxins12060395","volume":"12","author":"T De la Canales","year":"2020","unstructured":"De la Canales T. Efficacy and safety of botulinum toxin type A on persistent myofascial pain: A randomized clinical trial. Toxins. 2020;12(6):395.","journal-title":"Toxins"},{"issue":"1","key":"8514_CR29","doi-asserted-by":"publisher","first-page":"3031","DOI":"10.1038\/s41598-018-21474-y","volume":"8","author":"I La Fratta","year":"2018","unstructured":"La Fratta I, et al. The plasmatic and salivary levels of IL-1\u03b2, IL-18 and IL-6 are associated to emotional difference during stress in young male. Sci Rep. 2018;8(1):3031.","journal-title":"Sci Rep"},{"issue":"11","key":"8514_CR30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/JPER.22-0065","volume":"93","author":"A Enver","year":"2022","unstructured":"Enver A, et al. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases. J Periodontol. 2022;93(11):1649\u201360.","journal-title":"J Periodontol"},{"key":"8514_CR31","doi-asserted-by":"crossref","unstructured":"Cohen J. Statistical power analysis. American Psychological Society, 1, 98\u2013101. Cohen, J.(1992). A power primer. Psychological Bulletin, 1992; 112: 155\u2013159.","DOI":"10.1037\/0033-2909.112.1.155"},{"issue":"8","key":"8514_CR32","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1093\/ptj\/81.8.1464","volume":"81","author":"JA Sterne","year":"2001","unstructured":"Sterne JA. G.D. <>Smith 2001 Sifting the evidence\u2014what\u2019s wrong with significance tests? Phys Ther 81 8 1464\u20139.","journal-title":"Phys Ther"},{"issue":"1","key":"8514_CR33","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/toxins13010058","volume":"13","author":"S Choudhury","year":"2021","unstructured":"Choudhury S, et al. Botulinum toxin: an update on pharmacology and newer products in development. Toxins. 2021;13(1):58.","journal-title":"Toxins"},{"key":"8514_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuroscience.2011.04.026","volume":"186","author":"I Matak","year":"2011","unstructured":"Matak I, et al. Behavioral and immunohistochemical evidence for central antinociceptive activity of botulinum toxin A. Neuroscience. 2011;186:201\u20137.","journal-title":"Neuroscience"},{"key":"8514_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00702-013-1150-6","volume":"121","author":"V Drinovac","year":"2014","unstructured":"Drinovac V, Bach-Rojecky L, Lackovi\u0107 Z. Association of antinociceptive action of botulinum toxin type A with GABA-A receptor. J Neural Transm. 2014;121:665\u20139.","journal-title":"J Neural Transm"},{"issue":"8","key":"8514_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/papr.13396","volume":"24","author":"V Sitnikova","year":"2024","unstructured":"Sitnikova V, et al. Clinical benefit of botulinum toxin for treatment of persistent TMD-related myofascial pain: A randomized, placebo\u2010controlled, cross\u2010over trial. Pain Pract. 2024;24(8):1014\u201323.","journal-title":"Pain Pract"},{"key":"8514_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1744-8069-7-94","volume":"7","author":"R Cady","year":"2011","unstructured":"Cady R, et al. Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitization. Mol Pain. 2011;7:94\u201394.","journal-title":"Mol Pain"},{"issue":"4","key":"8514_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2535\/ofaj.93.127","volume":"93","author":"Y Azuma","year":"2017","unstructured":"Azuma Y, Sato I. The localization of calcitonin gene-related peptide in the human trigeminal ganglion and masseter muscle. Okajimas Folia Anat Jpn. 2017;93(4):127\u201338.","journal-title":"Okajimas Folia Anat Jpn"},{"issue":"3","key":"8514_CR39","first-page":"246","volume":"18","author":"J Carleson","year":"2004","unstructured":"Carleson J, Lundeberg T, Appelgren B. Muscle and brain changes of calcitonin gene-related peptide in experimentally induced unilateral rat masseter myositis. J Orofac Pain. 2004;18(3):246\u201352.","journal-title":"J Orofac Pain"},{"key":"8514_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2015.05.005","volume":"271","author":"M Romero-Reyes","year":"2015","unstructured":"Romero-Reyes M, Pardi V, Akerman S. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: role of CGRP in orofacial pain. Exp Neurol. 2015;271:95\u2013103.","journal-title":"Exp Neurol"},{"key":"8514_CR41","doi-asserted-by":"crossref","unstructured":"Tchivileva IE, Johnson KW, Chai X, VanDam LR, Lim PF, Slade GD. Evaluation of plasma calcitonin gene-related peptide as a biomarker for painful temporomandibular disorder and migraine. J Pain Res. 2023;16:2331\u201346.","DOI":"10.2147\/JPR.S408044"},{"issue":"1","key":"8514_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41584-020-00528-4","volume":"17","author":"BL Wise","year":"2021","unstructured":"Wise BL, Seidel MF, Lane NE. The evolution of nerve growth factor inhibition in clinical medicine. Nat Rev Rheumatol. 2021;17(1):34\u201346.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"8514_CR43","doi-asserted-by":"publisher","first-page":"311","DOI":"10.11607\/ofph.2623","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, et al. Comparison of Pain-Generated Functional Outcomes in Experimental Models of Delayed-Onset Muscle Soreness and Nerve Growth Factor Injection of the Masticatory Muscles. J oral facial pain headache. 2020;34(4):311\u201322.","journal-title":"J oral facial pain headache"},{"issue":"5","key":"8514_CR44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2842.2011.02271.x","volume":"39","author":"D Basi","year":"2012","unstructured":"Basi D, et al. Human temporomandibular joint and myofascial pain biochemical profiles: a case-control study. J Rehabil. 2012;39(5):326\u201337.","journal-title":"J Rehabil"},{"key":"8514_CR45","unstructured":"Svensson P, Castrillon E, Cairns BE. Nerve growth factor-evoked masseter muscle sensitization and perturbation of jaw motor function in healthy women. J Orofac Pain. 2008;22(4):295\u2013304."},{"key":"8514_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.neuroscience.2017.07.011","volume":"359","author":"S Cobianchi","year":"2017","unstructured":"Cobianchi S, et al. Botulinum neurotoxin A promotes functional recovery after peripheral nerve injury by increasing regeneration of myelinated fibers. Neuroscience. 2017;359:82\u201391.","journal-title":"Neuroscience"},{"issue":"12","key":"8514_CR47","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3390\/toxins15120691","volume":"15","author":"S Hwang","year":"2023","unstructured":"Hwang S, et al. Comparison of the effects of botulinum toxin doses on nerve regeneration in rats with experimentally induced sciatic nerve injury. Toxins. 2023;15(12):691.","journal-title":"Toxins"},{"issue":"7","key":"8514_CR48","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/toxins12070434","volume":"12","author":"S Luvisetto","year":"2020","unstructured":"Luvisetto S. Botulinum toxin and neuronal regeneration after traumatic injury of central and peripheral nervous system. Toxins. 2020;12(7):434.","journal-title":"Toxins"},{"key":"8514_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molmet.2019.06.024","volume":"28","author":"J Machado","year":"2019","unstructured":"Machado J, et al. \u03b1 \u2013\u2009Calcitonin gene-related peptide inhibits autophagy and calpain systems and maintains the stability of neuromuscular junction in denervated muscles. Mol Metabolism. 2019;28:91\u2013106.","journal-title":"Mol Metabolism"},{"key":"8514_CR50","doi-asserted-by":"crossref","unstructured":"Tarabal O, Calder\u00f3 J, Ribera J, Sorribas A, L\u00f3pez R, Molg\u00f3 J, et al. Regulation of motoneuronal calcitonin gene-related peptide (CGRP) during axonal growth and neuromuscular synaptic plasticity induced by botulinum toxin in rats. Eur J Neurosci. 1996;8(4):829\u201336.","DOI":"10.1111\/j.1460-9568.1996.tb01269.x"},{"key":"8514_CR51","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0960-8966(94)90089-2","volume":"4","author":"S Hassan","year":"1994","unstructured":"Hassan S, et al. Calcitonin gene-related peptide-like immunoreactivity, in botulinum toxin-paralysed rat muscles. Neuromuscul Disord. 1994;4:489\u201396.","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"8514_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5005\/jcdp-9-3-72","volume":"9","author":"PDV de Almeida","year":"2008","unstructured":"de Almeida PDV, et al. Saliva composition and functions: a comprehensive review. J contemp dent pract. 2008;9(3):72\u201380.","journal-title":"J contemp dent pract"},{"issue":"3","key":"8514_CR53","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/eos.12182","volume":"123","author":"A Prodan","year":"2015","unstructured":"Prodan A, et al. Interindividual variation, correlations, and sex-related differences in the salivary biochemistry of young healthy adults. Eur J Oral Sci. 2015;123(3):149\u201357.","journal-title":"Eur J Oral Sci"},{"issue":"1","key":"8514_CR54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/prd.12116","volume":"70","author":"GB Proctor","year":"2016","unstructured":"Proctor GB. The physiology of salivary secretion. Periodontol 2000. 2016;70(1):11\u201325.","journal-title":"Periodontol 2000"},{"issue":"7","key":"8514_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/joor.12977","volume":"47","author":"H Jasim","year":"2020","unstructured":"Jasim H, et al. Daytime changes of salivary biomarkers involved in pain. J Rehabil. 2020;47(7):843\u201350.","journal-title":"J Rehabil"},{"key":"8514_CR56","doi-asserted-by":"publisher","first-page":"BMI","DOI":"10.4137\/BMI.S607","volume":"3","author":"D Esser","year":"2008","unstructured":"Esser D, et al. Sample stability and protein composition of saliva: implications for its use as a diagnostic fluid. Biomark insights. 2008;3:BMI.","journal-title":"Biomark insights"},{"issue":"5","key":"8514_CR57","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1007\/s12031-020-01491-1","volume":"70","author":"S Ayoub","year":"2020","unstructured":"Ayoub S, Berb\u00e9ri A, Fayyad-Kazan M. Cytokines, masticatory muscle inflammation, and pain: an update. J Mol Neurosci. 2020;70(5):790\u20135.","journal-title":"J Mol Neurosci"},{"issue":"12","key":"8514_CR58","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1016\/j.pain.2011.09.005","volume":"152","author":"GD Slade","year":"2011","unstructured":"Slade GD, et al. Cytokine biomarkers and chronic pain: association of genes, transcription, and circulating proteins with temporomandibular disorders and widespread palpation tenderness. Pain. 2011;152(12):2802\u201312.","journal-title":"Pain"},{"issue":"12","key":"8514_CR59","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/pm\/pnac091","volume":"23","author":"K Canl\u0131","year":"2022","unstructured":"Canl\u0131 K, et al. Systemic cytokine level differences in patients with chronic musculoskeletal spinal pain compared to healthy controls and its association with pain severity: a systematic review. Pain Med. 2022;23(12):1947\u201364.","journal-title":"Pain Med"},{"issue":"9","key":"8514_CR60","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/jcm11092285","volume":"11","author":"B Karshikoff","year":"2022","unstructured":"Karshikoff B, et al. Baseline pro-inflammatory cytokine levels moderate psychological inflexibility in behavioral treatment for chronic pain. J Clin Med. 2022;11(9):2285.","journal-title":"J Clin Med"},{"issue":"24","key":"8514_CR61","doi-asserted-by":"publisher","first-page":"13412","DOI":"10.3390\/ijerph182413412","volume":"18","author":"LA Campos","year":"2021","unstructured":"Campos LA, et al. Use of oral health impact profile-14 (OHIP-14) in different contexts. What is being measured? Int J Environ Res Public Health. 2021;18(24):13412.","journal-title":"Int J Environ Res Public Health"},{"key":"8514_CR62","first-page":"24","volume":"111997","author":"D Locker","year":"1997","unstructured":"Locker D, Slade G. Concepts of oral health, disease and the quality of life. Measuring oral health Qual life. 1997;111997:24.","journal-title":"Measuring oral health Qual life"},{"key":"8514_CR63","doi-asserted-by":"crossref","unstructured":"Izzetti R, Carli E, Gennai S, Giuca MR, Graziani F, Nisi M. Treatment outcomes in patients with muscular temporomandibular joint disorders: a prospective case-control study. Dent J (Basel). 2024;12(5):129.","DOI":"10.3390\/dj12050129"},{"key":"8514_CR64","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.msksp.2020.102108","volume":"46","author":"L Calixtre","year":"2020","unstructured":"Calixtre L, et al. What is the minimal important difference of pain intensity, mandibular function, and headache impact in patients with temporomandibular disorders? Clinical significance analysis of a randomized controlled trial. Musculoskelet Sci Pract. 2020;46:102108.","journal-title":"Musculoskelet Sci Pract"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-026-08514-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-026-08514-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:03:00Z","timestamp":1779375780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12903-026-08514-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8514"],"URL":"https:\/\/doi.org\/10.1186\/s12903-026-08514-0","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical study was conducted in accordance with the principles of the Declaration of Helsinki and adheres to the TREND statement for non-randomized intervention studies. The study was registered at ClinicalTrials.gov (Identifier: NCT06840730, 2025-02-21). Ethical approval was obtained from the Hacettepe University Clinical Research Ethics Committee (GA-23004) and the Turkish Medicines and Medical Devices Agency (23-AKD-130). A non-treatment control group was not included due to the ethical obligation to treat patients experiencing pain. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"885"}}